{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T04:50:58Z","timestamp":1789275058042,"version":"build-2803163510"},"reference-count":101,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81100581"],"award-info":[{"award-number":["81100581"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"China International Medical Foundation (CIMF)-Novo Nordisk China diabetes Yingcai Funding","award":["2014"],"award-info":[{"award-number":["2014"]}]},{"name":"CIMF-Novo Nordisk China \u03b2 Academy Funding","award":["20110059"],"award-info":[{"award-number":["20110059"]}]},{"name":"Fundamental Research Funds for the Central Universities","award":["0118540208"],"award-info":[{"award-number":["0118540208"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.lfs.2017.11.026","type":"journal-article","created":{"date-parts":[[2017,11,20]],"date-time":"2017-11-20T20:16:21Z","timestamp":1511208981000},"page":"160-165","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":81,"special_numbering":"C","title":["Autoimmune thyroid diseases and Th17\/Treg lymphocytes"],"prefix":"10.1016","volume":"192","author":[{"given":"Shiying","family":"Shao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefeng","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liya","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.lfs.2017.11.026_bb0005","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0889-8529(05)70299-1","article-title":"The pathogenesis of Graves' disease","volume":"27","author":"McIver","year":"1998","journal-title":"Endocrinol. Metab. Clin. N. Am."},{"issue":"5","key":"10.1016\/j.lfs.2017.11.026_bb0010","first-page":"723","article-title":"Cell interactions in the induction of tolerance: the role of thymic lymphocytes","volume":"18","author":"Gershon","year":"1970","journal-title":"Immunology"},{"key":"10.1016\/j.lfs.2017.11.026_bb0015","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3389\/fimmu.2012.00178","article-title":"Multiple treg suppressive modules and their adaptability","volume":"3","author":"Wing","year":"2012","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2017.11.026_bb0020","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1034\/j.1600-065X.2001.1820105.x","article-title":"Type 1 T regulatory cells","volume":"182","author":"Roncarolo","year":"2001","journal-title":"Immunol. Rev."},{"issue":"5216","key":"10.1016\/j.lfs.2017.11.026_bb0025","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1126\/science.7770771","article-title":"Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor beta","volume":"268","author":"Suzuki","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.lfs.2017.11.026_bb0030","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0065-2776(03)81008-8","article-title":"Control of autoimmunity by naturally arising regulatory CD4+ T cells","volume":"81","author":"Hori","year":"2003","journal-title":"Adv. Immunol."},{"issue":"4","key":"10.1016\/j.lfs.2017.11.026_bb0035","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ni1178","article-title":"Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self","volume":"6","author":"Sakaguchi","year":"2005","journal-title":"Nat. Immunol."},{"issue":"7","key":"10.1016\/j.lfs.2017.11.026_bb0040","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.humimm.2015.06.003","article-title":"Quantitative and functional analysis of CD69(+) NKG2D(+) T regulatory cells in healthy subjects","volume":"76","author":"Vitales-Noyola","year":"2015","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.lfs.2017.11.026_bb0045","first-page":"39","article-title":"Tr1 cells and the counter-regulation of immunity: natural mechanisms and therapeutic applications","volume":"380","author":"Roncarolo","year":"2014","journal-title":"Curr. Top. Microbiol. Immunol."},{"issue":"9","key":"10.1016\/j.lfs.2017.11.026_bb0050","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/intimm\/9.9.1367","article-title":"Normal thymic selection, superantigen-induced deletion and Fas-mediated apoptosis of T cells in IL-2 receptor beta chain-deficient mice","volume":"9","author":"Suzuki","year":"1997","journal-title":"Int. Immunol."},{"issue":"9","key":"10.1016\/j.lfs.2017.11.026_bb0055","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1084\/jem.20040395","article-title":"Essential roles of CD8+CD122+ regulatory T cells in the maintenance of T cell homeostasis","volume":"200","author":"Rifa'i","year":"2004","journal-title":"J. Exp. Med."},{"issue":"11","key":"10.1016\/j.lfs.2017.11.026_bb0060","doi-asserted-by":"crossref","first-page":"7093","DOI":"10.4049\/jimmunol.175.11.7093","article-title":"Cutting edge: CD8+CD122+ regulatory T cells produce IL-10 to suppress IFN-gamma production and proliferation of CD8+ T cells","volume":"175","author":"Endharti","year":"2005","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.lfs.2017.11.026_bb0065","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1074\/jbc.M207577200","article-title":"Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17","volume":"278","author":"Aggarwal","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.lfs.2017.11.026_bb0070","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.immuni.2008.05.007","article-title":"Molecular antagonism and plasticity of regulatory and inflammatory T cell programs","volume":"29","author":"Yang","year":"2008","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.lfs.2017.11.026_bb0075","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.cellimm.2012.11.001","article-title":"Th17 cells in type 1 diabetes","volume":"280","author":"Shao","year":"2012","journal-title":"Cell. Immunol."},{"issue":"1","key":"10.1016\/j.lfs.2017.11.026_bb0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1189\/jlb.71.1.1","article-title":"IL-17: prototype member of an emerging cytokine family","volume":"71","author":"Aggarwal","year":"2002","journal-title":"J. Leukoc. Biol."},{"issue":"6","key":"10.1016\/j.lfs.2017.11.026_bb0085","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.cell.2006.07.035","article-title":"The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells","volume":"126","author":"Ivanov","year":"2006","journal-title":"Cell"},{"issue":"7318","key":"10.1016\/j.lfs.2017.11.026_bb0090","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/nature09447","article-title":"Generation of pathogenic T(H)17 cells in the absence of TGF-beta signalling","volume":"467","author":"Ghoreschi","year":"2010","journal-title":"Nature"},{"issue":"7446","key":"10.1016\/j.lfs.2017.11.026_bb0095","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/nature11984","article-title":"Induction of pathogenic TH17 cells by inducible salt-sensing kinase SGK1","volume":"496","author":"Wu","year":"2013","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.lfs.2017.11.026_bb0100","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/nri3464","article-title":"The plasticity and stability of regulatory T cells","volume":"13","author":"Sakaguchi","year":"2013","journal-title":"Nat. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.lfs.2017.11.026_bb0105","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.clim.2008.12.008","article-title":"IL-1beta and IL-2 convert human Treg into T(H)17 cells","volume":"131","author":"Deknuydt","year":"2009","journal-title":"Clin. Immunol."},{"issue":"2","key":"10.1016\/j.lfs.2017.11.026_bb0110","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00262-003-0444-1","article-title":"Anti-tumor immunity and autoimmunity: a balancing act of regulatory T cells","volume":"53","author":"Wei","year":"2004","journal-title":"Cancer Immunol. Immunother."},{"issue":"18","key":"10.1016\/j.lfs.2017.11.026_bb0115","doi-asserted-by":"crossref","first-page":"8471","DOI":"10.1158\/0008-5472.CAN-05-0934","article-title":"Concurrent induction of antitumor immunity and autoimmune thyroiditis in CD4+ CD25+ regulatory T cell-depleted mice","volume":"65","author":"Wei","year":"2005","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.lfs.2017.11.026_bb0120","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1210\/en.2005-1024","article-title":"Regulation of Graves' hyperthyroidism with naturally occurring CD4+CD25+ regulatory T cells in a mouse model","volume":"147","author":"Saitoh","year":"2006","journal-title":"Endocrinology"},{"issue":"12","key":"10.1016\/j.lfs.2017.11.026_bb0125","doi-asserted-by":"crossref","first-page":"6040","DOI":"10.1210\/en.2007-0300","article-title":"CD8+CD122+ T cells, a newly identified regulatory T subset, negatively regulate Graves' hyperthyroidism in a murine model","volume":"148","author":"Saitoh","year":"2007","journal-title":"Endocrinology"},{"issue":"12","key":"10.1016\/j.lfs.2017.11.026_bb0130","doi-asserted-by":"crossref","first-page":"5724","DOI":"10.1210\/en.2007-1024","article-title":"The link between Graves' disease and Hashimoto's thyroiditis: a role for regulatory T cells","volume":"148","author":"McLachlan","year":"2007","journal-title":"Endocrinology"},{"issue":"11","key":"10.1016\/j.lfs.2017.11.026_bb0135","doi-asserted-by":"crossref","first-page":"7433","DOI":"10.4049\/jimmunol.174.11.7433","article-title":"Tolerogenic semimature dendritic cells suppress experimental autoimmune thyroiditis by activation of thyroglobulin-specific CD4+CD25+ T cells","volume":"174","author":"Verginis","year":"2005","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.lfs.2017.11.026_bb0140","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s10238-011-0137-6","article-title":"Regulatory T cells but not T helper 17 cells are modulated in an animal model of Graves' hyperthyroidism","volume":"12","author":"Zhou","year":"2012","journal-title":"Clin. Exp. Med."},{"issue":"8","key":"10.1016\/j.lfs.2017.11.026_bb0145","doi-asserted-by":"crossref","first-page":"4734","DOI":"10.4049\/jimmunol.0904135","article-title":"Impairment of regulatory capacity of CD4+CD25+ regulatory T cells mediated by dendritic cell polarization and hyperthyroidism in Graves' disease","volume":"186","author":"Mao","year":"2011","journal-title":"J. Immunol."},{"issue":"1-2","key":"10.1016\/j.lfs.2017.11.026_bb0150","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1159\/000452541","article-title":"Imbalance of Th17\/Treg in Different Subtypes of Autoimmune Thyroid Diseases","volume":"40","author":"Li","year":"2016","journal-title":"Cell. Physiol. Biochem."},{"issue":"4","key":"10.1016\/j.lfs.2017.11.026_bb0155","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1365-2265.2009.03544.x","article-title":"Regulatory T cells in Graves' disease","volume":"71","author":"Pan","year":"2009","journal-title":"Clin. Endocrinol."},{"issue":"3","key":"10.1016\/j.lfs.2017.11.026_bb0160","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s12020-015-0569-y","article-title":"The possible role of CD4(+)CD25(high)Foxp3(+)\/CD4(+)IL-17A(+) cell imbalance in the autoimmunity of patients with Hashimoto thyroiditis","volume":"50","author":"Xue","year":"2015","journal-title":"Endocrine"},{"issue":"7","key":"10.1016\/j.lfs.2017.11.026_bb0165","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1089\/thy.2012.0514","article-title":"Impairment of regulatory T-cell function in autoimmune thyroid disease","volume":"23","author":"Glick","year":"2013","journal-title":"Thyroid"},{"issue":"9","key":"10.1016\/j.lfs.2017.11.026_bb0170","doi-asserted-by":"crossref","first-page":"3639","DOI":"10.1210\/jc.2005-2337","article-title":"Regulatory T cells in human autoimmune thyroid disease","volume":"91","author":"Marazuela","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.lfs.2017.11.026_bb0175","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3109\/08916934.2012.751981","article-title":"Lower proportions of CD4+CD25(high) and CD4+FoxP3, but not CD4+CD25+CD127(low) FoxP3+ T cell levels in children with autoimmune thyroid diseases","volume":"46","author":"Bossowski","year":"2013","journal-title":"Autoimmunity"},{"issue":"3","key":"10.1016\/j.lfs.2017.11.026_bb0180","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/s12020-015-0662-2","article-title":"Levels of regulatory T cells CD69(+)NKG2D(+)IL-10(+) are increased in patients with autoimmune thyroid disorders","volume":"51","author":"Rodriguez-Munoz","year":"2016","journal-title":"Endocrine"},{"issue":"1","key":"10.1016\/j.lfs.2017.11.026_bb0185","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.cellimm.2013.02.002","article-title":"Functional interleukin-17 receptor A are present in the thyroid gland in intractable Graves disease","volume":"281","author":"Li","year":"2013","journal-title":"Cell. Immunol."},{"issue":"7","key":"10.1016\/j.lfs.2017.11.026_bb0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0068446","article-title":"A high frequency of circulating th22 and th17 cells in patients with new onset graves' disease","volume":"8","author":"Peng","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2017.11.026_bb0195","doi-asserted-by":"crossref","first-page":"609593","DOI":"10.1155\/2015\/609593","article-title":"Th1, Th2, and Th17 Cytokine Involvement in Thyroid Associated Ophthalmopathy","volume":"2015","author":"Shen","year":"2015","journal-title":"Dis. Markers"},{"issue":"11","key":"10.1016\/j.lfs.2017.11.026_bb0200","doi-asserted-by":"crossref","first-page":"5135","DOI":"10.1210\/en.2009-0434","article-title":"T helper type 17 immune response plays an indispensable role for development of iodine-induced autoimmune thyroiditis in nonobese diabetic-H2h4 mice","volume":"150","author":"Horie","year":"2009","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.lfs.2017.11.026_bb0205","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/cei.12557","article-title":"Altered balance between self-reactive T helper (Th)17 cells and Th10 cells and between full-length forkhead box protein 3 (FoxP3) and FoxP3 splice variants in Hashimoto's thyroiditis","volume":"180","author":"Kristensen","year":"2015","journal-title":"Clin. Exp. Immunol."},{"issue":"3","key":"10.1016\/j.lfs.2017.11.026_bb0210","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.clim.2013.10.001","article-title":"Th17 cell plays a role in the pathogenesis of Hashimoto's thyroiditis in patients","volume":"149","author":"Li","year":"2013","journal-title":"Clin. Immunol."},{"issue":"5","key":"10.1016\/j.lfs.2017.11.026_bb0215","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1089\/thy.2008.0423","article-title":"Increases of the Th1\/Th2 cell ratio in severe Hashimoto's disease and in the proportion of Th17 cells in intractable Graves' disease","volume":"19","author":"Nanba","year":"2009","journal-title":"Thyroid"},{"issue":"2","key":"10.1016\/j.lfs.2017.11.026_bb0220","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1210\/jc.2009-1719","article-title":"Increased circulating pro-inflammatory cytokines and Th17 lymphocytes in Hashimoto's thyroiditis","volume":"95","author":"Figueroa-Vega","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"12","key":"10.1016\/j.lfs.2017.11.026_bb0225","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1590\/S0100-879X2012007500168","article-title":"The increased but non-predominant expression of Th17- and Th1-specific cytokines in Hashimoto's thyroiditis but not in Graves' disease","volume":"45","author":"Qin","year":"2012","journal-title":"Braz. J. Med. Biol. Res."},{"issue":"3","key":"10.1016\/j.lfs.2017.11.026_bb0230","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1365-2249.2009.04034.x","article-title":"Association of the -31C\/T functional polymorphism in the interleukin-1beta gene with the intractability of Graves' disease and the proportion of T helper type 17 cells","volume":"158","author":"Hayashi","year":"2009","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.lfs.2017.11.026_bb0235","doi-asserted-by":"crossref","DOI":"10.1007\/s12020-017-1361-y","article-title":"Pathogenic Th17 and Th22 cells are increased in patients with autoimmune thyroid disorders","author":"Vitales-Noyola","year":"2017","journal-title":"Endocrine"},{"issue":"10","key":"10.1016\/j.lfs.2017.11.026_bb0240","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1007\/s00417-012-2092-7","article-title":"Increased serum interleukin-17 in Graves' ophthalmopathy","volume":"250","author":"Kim","year":"2012","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"issue":"14","key":"10.1016\/j.lfs.2017.11.026_bb0245","doi-asserted-by":"crossref","first-page":"6123","DOI":"10.1167\/iovs.16-20199","article-title":"IL-17A Promotes RANTES Expression, But Not IL-16, in Orbital Fibroblasts Via CD40-CD40L Combination in Thyroid-Associated Ophthalmopathy","volume":"57","author":"Fang","year":"2016","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"7","key":"10.1016\/j.lfs.2017.11.026_bb0250","doi-asserted-by":"crossref","first-page":"533","DOI":"10.3109\/08916934.2012.702814","article-title":"Association of interleukin-17A and -17F gene single-nucleotide polymorphisms with autoimmune thyroid diseases","volume":"45","author":"Yan","year":"2012","journal-title":"Autoimmunity"},{"issue":"3","key":"10.1016\/j.lfs.2017.11.026_bb0255","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1210\/jc.2007-2190","article-title":"Interleukin (IL)-23 receptor is a major susceptibility gene for Graves' ophthalmopathy: the IL-23\/T-helper 17 axis extends to thyroid autoimmunity","volume":"93","author":"Huber","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.lfs.2017.11.026_bb0260","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1210\/jc.2010-1424","article-title":"Regulatory T-cells in Graves' orbitopathy: baseline findings and immunomodulation by anti-T lymphocyte globulin","volume":"96","author":"Kahaly","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"9","key":"10.1016\/j.lfs.2017.11.026_bb0265","doi-asserted-by":"crossref","first-page":"4246","DOI":"10.1210\/jc.2003-030380","article-title":"Relative overexpression of macrophage-derived cytokines in orbital adipose tissue from patients with graves' ophthalmopathy","volume":"88","author":"Kumar","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.lfs.2017.11.026_bb0270","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1046\/j.1365-2265.2003.01708.x","article-title":"TSH-R expression and cytokine profile in orbital tissue of active vs. inactive Graves' ophthalmopathy patients","volume":"58","author":"Wakelkamp","year":"2003","journal-title":"Clin. Endocrinol."},{"issue":"8","key":"10.1016\/j.lfs.2017.11.026_bb0275","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1007\/s00125-014-3262-4","article-title":"Human mesenchymal stem cell-derived microvesicles modulate T cell response to islet antigen glutamic acid decarboxylase in patients with type 1 diabetes","volume":"57","author":"Favaro","year":"2014","journal-title":"Diabetologia"},{"issue":"12","key":"10.1016\/j.lfs.2017.11.026_bb0280","doi-asserted-by":"crossref","first-page":"E1531","DOI":"10.1210\/jc.2015-3146","article-title":"Circulating Microvesicles Regulate Treg and Th17 Differentiation in Human Autoimmune Thyroid Disorders","volume":"100","author":"Rodriguez-Munoz","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.lfs.2017.11.026_bb0285","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1172\/JCI83013","article-title":"SLAMF1 regulation of chemotaxis and autophagy determines CLL patient response","volume":"126","author":"Bologna","year":"2016","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.lfs.2017.11.026_bb0290","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1210\/jc.2016-2322","article-title":"Expression and Function of the Costimulatory Receptor SLAMF1 Is Altered in Lymphocytes From Patients With Autoimmune Thyroiditis","volume":"102","author":"Vitales-Noyola","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.lfs.2017.11.026_bb0295","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s40618-016-0594-6","article-title":"The thyroid, the eyes and the gut: a possible connection","volume":"40","author":"Covelli","year":"2017","journal-title":"J. Endocrinol. Investig."},{"issue":"4","key":"10.1016\/j.lfs.2017.11.026_bb0300","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.immuni.2009.08.020","article-title":"The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses","volume":"31","author":"Gaboriau-Routhiau","year":"2009","journal-title":"Immunity"},{"issue":"6015","key":"10.1016\/j.lfs.2017.11.026_bb0305","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1126\/science.1198469","article-title":"Induction of colonic regulatory T cells by indigenous Clostridium species","volume":"331","author":"Atarashi","year":"2011","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.lfs.2017.11.026_bb0310","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nri3198","article-title":"Regulation and function of mTOR signalling in T cell fate decisions","volume":"12","author":"Chi","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.lfs.2017.11.026_bb0315","doi-asserted-by":"crossref","DOI":"10.1096\/fj.201600522R","article-title":"The AMP analog AICAR modulates the Treg\/Th17 axis through enhancement of fatty acid oxidation","author":"Gualdoni","year":"2016","journal-title":"FASEB J."},{"issue":"8","key":"10.1016\/j.lfs.2017.11.026_bb0320","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1172\/JCI13505","article-title":"Role of AMP-activated protein kinase in mechanism of metformin action","volume":"108","author":"Zhou","year":"2001","journal-title":"J. Clin. Invest."},{"issue":"10","key":"10.1016\/j.lfs.2017.11.026_bb0325","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/nrm2249","article-title":"AMP-activated\/SNF1 protein kinases: conserved guardians of cellular energy","volume":"8","author":"Hardie","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"3","key":"10.1016\/j.lfs.2017.11.026_bb0330","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/j.1582-4934.2011.01347.x","article-title":"mTOR-STAT3-notch signalling contributes to ALDH2-induced protection against cardiac contractile dysfunction and autophagy under alcoholism","volume":"16","author":"Ge","year":"2012","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.lfs.2017.11.026_bb0335","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.trsl.2016.03.006","volume":"173","author":"Park","year":"2016","journal-title":"Transl. Res."},{"issue":"1","key":"10.1016\/j.lfs.2017.11.026_bb0340","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.intimp.2013.03.020","article-title":"Metformin downregulates Th17 cells differentiation and attenuates murine autoimmune arthritis","volume":"16","author":"Kang","year":"2013","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.lfs.2017.11.026_bb0345","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jneuroim.2016.01.014","article-title":"Metformin ameliorates the development of experimental autoimmune encephalomyelitis by regulating T helper 17 and regulatory T cells in mice","volume":"292","author":"Sun","year":"2016","journal-title":"J. Neuroimmunol."},{"issue":"7","key":"10.1016\/j.lfs.2017.11.026_bb0350","doi-asserted-by":"crossref","first-page":"4158","DOI":"10.1167\/iovs.11-9323","article-title":"Aminoimidazole carboxamide ribonucleotide ameliorates experimental autoimmune uveitis","volume":"53","author":"Suzuki","year":"2012","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"9","key":"10.1016\/j.lfs.2017.11.026_bb0355","article-title":"Metformin Ameliorates Inflammatory Bowel Disease by Suppression of the STAT3 Signaling Pathway and Regulation of the between Th17\/Treg Balance","volume":"10","author":"Lee","year":"2015","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.lfs.2017.11.026_bb0360","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1136\/annrheumdis-2014-206028","article-title":"The JAK inhibitor tofacitinib suppresses synovial JAK1-STAT signalling in rheumatoid arthritis","volume":"74","author":"Boyle","year":"2015","journal-title":"Ann. Rheum. Dis."},{"issue":"9","key":"10.1016\/j.lfs.2017.11.026_bb0365","doi-asserted-by":"crossref","first-page":"4417","DOI":"10.4049\/jimmunol.1300514","article-title":"JAK2-STAT3 blockade by AG490 suppresses autoimmune arthritis in mice via reciprocal regulation of regulatory T Cells and Th17 cells","volume":"192","author":"Park","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.lfs.2017.11.026_bb0370","article-title":"The role of IL-12\/23 in T cell-related chronic inflammation: implications of immunodeficiency and therapeutic blockade","author":"Schurich","year":"2017","journal-title":"Rheumatology"},{"issue":"4","key":"10.1016\/j.lfs.2017.11.026_bb0375","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/art.38305","article-title":"STA-21, a promising STAT-3 inhibitor that reciprocally regulates Th17 and Treg cells, inhibits osteoclastogenesis in mice and humans and alleviates autoimmune inflammation in an experimental model of rheumatoid arthritis","volume":"66","author":"Park","year":"2014","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.lfs.2017.11.026_bb0380","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.bcp.2016.10.012","article-title":"Psoriatic inflammation enhances allergic airway inflammation through IL-23\/STAT3 signaling in a murine model","volume":"124","author":"Nadeem","year":"2017","journal-title":"Biochem. Pharmacol."},{"issue":"52","key":"10.1016\/j.lfs.2017.11.026_bb0385","doi-asserted-by":"crossref","first-page":"52ra72","DOI":"10.1126\/scitranslmed.3001107","article-title":"Effects of AIN457, a fully human antibody to interleukin-17A, on psoriasis, rheumatoid arthritis, and uveitis","volume":"2","author":"Hueber","year":"2010","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.lfs.2017.11.026_bb0390","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2147\/TCRM.S111107","article-title":"Role of IL-17 in plaque psoriasis: therapeutic potential of ixekizumab","volume":"13","author":"Hanley","year":"2017","journal-title":"Ther. Clin. Risk Manag."},{"issue":"6","key":"10.1016\/j.lfs.2017.11.026_bb0395","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1080\/17425255.2017.1325874","article-title":"Pharmacokinetic drug evaluation of brodalumab for the treatment of psoriasis","volume":"13","author":"Galluzzo","year":"2017","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"issue":"4","key":"10.1016\/j.lfs.2017.11.026_bb0400","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.ad.2016.09.021","article-title":"Clinical Efficacy and Safety of Ixekizumab for Treatment of Psoriasis","volume":"108","author":"Azevedo","year":"2017","journal-title":"Actas Dermosifiliogr."},{"key":"10.1016\/j.lfs.2017.11.026_bb0405","author":"Wei","year":"2017","journal-title":"Adv. Ther."},{"key":"10.1016\/j.lfs.2017.11.026_bb0410","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.2147\/DDDT.S100302","article-title":"Profile of sarilumab and its potential in the treatment of rheumatoid arthritis","volume":"11","author":"Raimondo","year":"2017","journal-title":"Drug Des. Devel. Ther."},{"issue":"3","key":"10.1016\/j.lfs.2017.11.026_bb0415","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/cei.12017","article-title":"Effect of interleukin-6 receptor blockade on the balance between regulatory T cells and T helper type 17 cells in rheumatoid arthritis patients","volume":"171","author":"Pesce","year":"2013","journal-title":"Clin. Exp. Immunol."},{"issue":"5","key":"10.1016\/j.lfs.2017.11.026_bb0420","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1136\/annrheumdis-2016-210070","article-title":"An expanded population of pathogenic regulatory T cells in giant cell arteritis is abrogated by IL-6 blockade therapy","volume":"76","author":"Miyabe","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.lfs.2017.11.026_bb0425","doi-asserted-by":"crossref","DOI":"10.2217\/cer-2017-0022","article-title":"Efficacy and safety of ustekinumab in the induction therapy of TNF-alpha-refractory Crohn's disease patients: a systematic review and meta-analysis","author":"Kawalec","year":"2017","journal-title":"J. Comp. Eff. Res."},{"issue":"9","key":"10.1016\/j.lfs.2017.11.026_bb0430","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.yexcr.2011.01.024","article-title":"Anti-cytokine therapies for psoriasis","volume":"317","author":"Nograles","year":"2011","journal-title":"Exp. Cell Res."},{"issue":"1","key":"10.1016\/j.lfs.2017.11.026_bb0435","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.clim.2006.12.006","article-title":"Increased expression of the FoxP3 functional marker of regulatory T cells following B cell depletion with rituximab in patients with lupus nephritis","volume":"123","author":"Sfikakis","year":"2007","journal-title":"Clin. Immunol."},{"issue":"5","key":"10.1016\/j.lfs.2017.11.026_bb0440","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1002\/art.39031","article-title":"Methotrexate Restores Regulatory T Cell Function Through Demethylation of the FoxP3 Upstream Enhancer in Patients With Rheumatoid Arthritis","volume":"67","author":"Cribbs","year":"2015","journal-title":"Arthritis Rheum."},{"issue":"4","key":"10.1016\/j.lfs.2017.11.026_bb0445","doi-asserted-by":"crossref","first-page":"422","DOI":"10.4158\/EP.14.4.422","article-title":"Use of methotrexate to treat isolated Graves ophthalmopathy developing years after thyroidectomy and iodine 131 treatment of papillary thyroid cancer","volume":"14","author":"Sanyal","year":"2008","journal-title":"Endocr. Pract."},{"issue":"2","key":"10.1016\/j.lfs.2017.11.026_bb0450","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.3892\/etm.2016.3367","article-title":"Clinical efficacy of combined rituximab treatment in a woman with severe Graves' ophthalmopathy","volume":"12","author":"Liu","year":"2016","journal-title":"Exp. Ther. Med."},{"issue":"2","key":"10.1016\/j.lfs.2017.11.026_bb0455","first-page":"R101-R9","article-title":"MANAGEMENT OF ENDOCRINE DISEASE: Rituximab therapy for Graves' orbitopathy - lessons from randomized control trials","volume":"176","author":"Stan","year":"2017","journal-title":"Eur. J. Endocrinol. \/ Eur. Fed. Endocr. Soc."},{"issue":"2","key":"10.1016\/j.lfs.2017.11.026_bb0460","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S2213-8587(16)30046-8","article-title":"Advances in treatment of active, moderate-to-severe Graves' ophthalmopathy","volume":"5","author":"Wiersinga","year":"2017","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"7344","key":"10.1016\/j.lfs.2017.11.026_bb0465","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nature09978","article-title":"Digoxin and its derivatives suppress TH17 cell differentiation by antagonizing RORgammat activity","volume":"472","author":"Huh","year":"2011","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.lfs.2017.11.026_bb0470","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1038\/aps.2014.58","article-title":"Ursolic acid ameliorates autoimmune arthritis via suppression of Th17 and B cell differentiation","volume":"35","author":"Baek","year":"2014","journal-title":"Acta Pharmacol. Sin."},{"issue":"4","key":"10.1016\/j.lfs.2017.11.026_bb0475","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.immuni.2014.04.004","article-title":"Small-molecule RORgammat antagonists inhibit T helper 17 cell transcriptional network by divergent mechanisms","volume":"40","author":"Xiao","year":"2014","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.lfs.2017.11.026_bb0480","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jdermsci.2016.10.001","article-title":"Oral administration of a novel RORgammat antagonist attenuates psoriasis-like skin lesion of two independent mouse models through neutralization of IL-17","volume":"85","author":"Takaishi","year":"2017","journal-title":"J. Dermatol. Sci."},{"issue":"2","key":"10.1016\/j.lfs.2017.11.026_bb0485","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0147979","article-title":"Development of a Topical Treatment for Psoriasis Targeting RORgamma: From Bench to Skin","volume":"11","author":"Smith","year":"2016","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.lfs.2017.11.026_bb0490","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1517\/13543776.2016.1153066","article-title":"Retinoid-related orphan receptor gamma t (RORgammat) inhibitors from Vitae Pharmaceuticals (WO2015116904) and structure proposal for their Phase I candidate VTP-43742","volume":"26","author":"Gege","year":"2016","journal-title":"Expert Opin. Ther. Pat."},{"issue":"4","key":"10.1016\/j.lfs.2017.11.026_bb0495","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.4049\/jimmunol.1500849","article-title":"Foxo1 Is a T Cell-Intrinsic Inhibitor of the RORgammat-Th17 Program","volume":"195","author":"Laine","year":"2015","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.lfs.2017.11.026_bb0500","doi-asserted-by":"crossref","first-page":"4219","DOI":"10.1007\/s11033-010-0544-x","article-title":"Comparison of gene expression profiles reveals aberrant expression of FOXO1, Aurora A\/B and EZH2 in lesional psoriatic skins","volume":"38","author":"Liu","year":"2011","journal-title":"Mol. Biol. Rep."},{"issue":"6","key":"10.1016\/j.lfs.2017.11.026_bb0505","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1007\/s10875-012-9716-x","article-title":"Etanercept downregulates the Th17 pathway and decreases the IL-17+\/IL-10+ cell ratio in patients with psoriasis vulgaris","volume":"32","author":"Antiga","year":"2012","journal-title":"J. Clin. Immunol."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320517306033?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320517306033?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T20:14:02Z","timestamp":1758399242000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320517306033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":101,"alternative-id":["S0024320517306033"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2017.11.026","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoimmune thyroid diseases and Th17\/Treg lymphocytes","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2017.11.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}